The CombiScreen® mALB/CREA is an innovative diagnostic test designed for the detection of microalbuminuria, a crucial indicator of kidney health, particularly in individuals with chronic diseases such as diabetes and hypertension. This product, branded ANALYTICON, is available in packs of 25 pieces, making it a practical and economical choice for health professionals and laboratories.

Why is Microalbuminuria Detection Important?

Microalbuminuria is an early signal of kidney damage and can indicate an increased risk of developing kidney diseases. Monitoring albumin levels in urine is essential for:

• Early identification of patients at risk of kidney disease.


• Assessing the effectiveness of ongoing treatments for diabetes and hypertension.


• Preventing long-term complications related to kidney health.

Features of the CombiScreen® mALB/CREA

The test offers numerous advantages, including:

• Albumin/Creatinine Ratio: Provides accurate information on albumin levels in urine, regardless of urinary concentration.


• Low Detection Limit: With a detection limit of only 22 mg/L of albumin, the test allows for reliable and timely screening.


• Ease of Use: The test is simple to perform and does not require complex sample collection; only a urine sample is needed.


• Quick Results: Results can be obtained in a short time, facilitating rapid clinical decisions.

Indications for Use

The CombiScreen® mALB/CREA is ideal for:

• General practitioners and specialists monitoring patients with chronic diseases.


• Clinical analysis laboratories needing quick and reliable tests.


• Public health screening programs aimed at preventing kidney diseases.

Conclusion

Investing in the CombiScreen® mALB/CREA means ensuring effective monitoring of kidney health for at-risk patients. With its ease of use, quick results, and low cost, it represents an ideal choice for those looking to keep their patients' health under control.